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B A C K G R O U N D :  This quasi-experimental cohort study 
aimed to evaluate World Health Organization (WHO) 
defi ned tuberculosis (TB) treatment outcomes for pa-
tients under directly observed treatment at a health fa-
cility (clinic DOT) or at home (family DOT) in urban 
Pakistan. 
M E T H O D S :  We enrolled 582 sputum smear-positive TB 
patients being treated by either clinic DOT (n = 295) or 
family DOT (n = 287) in 11 treatment centres. Patients 
and/or family members were interviewed for baseline 
measurements. WHO-defi ned treatment outcomes were 
evaluated at the end of treatment. Proportions of ‘cured’ 
patients were computed. A log-binomial model was used 
to evaluate the associations of various factors with ‘cured’ 
status.
R E S U LT S :  The proportion of ‘cured’ patients was re-
spectively 66% and 34% in the clinic DOT and family 
DOT groups (risk difference 0.32; 95%CI 0.24–0.39). 
Patients on clinic DOT were more likely to achieve cure 
(adjusted relative risk [RRadj] 1.85; 95%CI 1.43–2.39) 
than those on family DOT, as were patients satisfi ed with 
their health care worker’s attitude (RRadj 5.73; 95%CI 
2.54–12.96). 
C O N C L U S I O N :  Clinic DOT nearly doubled the propor-
tion of cured patients compared to family DOT. Efforts 
to improve care-provider attitudes to enhance patient 
satisfaction, and effective implementation of the WHO’s 
public-private mix approach, may enhance TB control 
in this and similar settings. 
K E Y  W O R D S :  pulmonary tuberculosis; DOT; cure rate; 
log-binomial regression model; Pakistan
GLOBALLY, tuberculosis (TB) is a leading cause of 
morbidity and mortality, with an estimated 8.9–9.9 mil-
lion incident cases, 9.6–13.3 million prevalent cases 
and 1.1–1.7 million deaths in 2008.1 The DOTS strat-
egy remains the cornerstone of global TB control ef-
forts.2,3 Notwithstanding successes in many regions, 
global incidence continues to increase, although at a 
slower rate, and has not fallen even in certain coun-
tries that have achieved good results under DOTS.4–7
In 2007, with an annual incidence of all types of 
TB of 181 per 100 000 population, an incidence of 
sputum smear-positive TB of 81/100 000 and a prev-
alence of TB all types of 223/100 000, Pakistan 
ranked eighth among the 22 high-burden TB coun-
tries.8 In 1995, Pakistan’s National Tuberculosis Pro-
gramme (NTP) adopted the DOTS strategy as its 
policy for TB care.9 However, the health system is 
overwhelmed and cannot cope with caseloads due to 
a lack of funds and/or dysfunctional politics, result-
ing in suboptimal implementation of the DOTS strat-
egy and seriously compromising the effectiveness of 
TB control in Pakistan.10 So far, in Pakistan and per-
haps in other similar resource-poor settings, it has 
not been practical to apply universal DOTS coverage. 
Because the majority of patients are very poor, and 
many are labourers or housewives, parallel non-
DOTS modalities are also used to avoid incurring ad-
ditional costs due to travel to health centres and re-
lated loss of earnings. As a result, treatment outcome 
targets for most TB patients are below target. 
All TB patient treatment outcomes should be rou-
tinely monitored to assess progress, identify and ad-
dress defi ciencies in the NTP and minimise and con-
trol multidrug-resistant disease.11 To improve patient 
adherence to treatment, directly observed treatment 
(DOT), one of the essential elements of the DOTS 
strategy, has been recommended for implementa-
tion in both health facilities and in the community 
in resource-constrained settings.12 Elsewhere, DOT at 
both health facilities and in the family have reached 
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World Health Organization (WHO) targets of 85% 
success.13 However, there is a paucity of published data 
on the effectiveness of such approaches in Pakistan.
This cohort study aimed to evaluate WHO-defi ned 
TB treatment outcomes with DOT supervised at a 
health facility (clinic DOT) and supervised by a family 
member (family DOT) in urban Karachi, Pakistan. 
METHODS
Study setting 
This study was conducted at TB treatment centres in 
Karachi, Pakistan’s largest city and the nation’s eco-
nomic hub, with a metropolitan area of 3530 km2 
and a population of 17 million. Pakistan’s private 
sector makes a major contribution to providing 
health care, particularly in major cities. Although TB 
control is primarily the responsibility of the govern-
ment health services, approximately 80% of TB pa-
tients consult a private practitioner for initial diag-
nosis and treatment.14 Karachi’s large private sector 
treats many TB patients without following the rec-
ommended guidelines.15 
In Karachi, health care is supported by a network 
of 85 government-approved hospitals and clinics in 
both the public (n = 18) and the private sector (n = 
67). Health practitioner backgrounds range from 
fully trained to traditional practitioners.16 At present, 
62 medical centres offer TB treatment: 36 in the pub-
lic sector and 26 in the private sector. Eleven centres 
were selected as a convenience sample based on will-
ingness of management to cooperate during the study 
period, and were regarded as being typical of TB 
treatment centres in Karachi and elsewhere in Paki-
stan. Of these, fi ve were run by non-governmental or-
ganisations, which use only family DOT, and fi ve 
were in the public sector, which uses only the clinic 
DOT strategy. One ‘semi-public’ centre (regarded as 
public sector in our analysis) offers both clinic and 
family DOT. The 11 centres consisted of fi ve tertiary-
care hospitals, one Institute of Chest Diseases, one 
community clinic for chest diseases and four general 
hospitals. 
Patients and study design 
We enrolled pulmonary TB (PTB) patients aged 
⩾15 years who had started a course of treatment 
(new or retreatment patient) at any of the 11 centres. 
A ‘new patient’ was defi ned as a TB patient who had 
never previously received treatment or had received 
treatment for <1 month. A ‘retreatment patient’ was 
defi ned as a TB patient who had received treatment 
for ⩾1 month from any source, and who had returned 
to treatment after default, i.e., who had not taken 
anti-tuberculosis drugs consecutively for ⩾2 months 
and who was found to be sputum smear-positive. The 
diagnosis of sputum smear-positive TB was made ac-
cording to WHO/International Union Against Tuber-
culosis and Lung Disease (The Union) criteria,17 in-
cluding: 1) two or more initial sputum smear 
examinations positive for acid-fast bacilli (AFB); or 
2) one sputum smear examination positive for AFB 
and radiographic abnormalities consistent with ac-
tive PTB determined by a clinician; or 3) one sputum 
smear positive for AFB plus sputum culture positive 
for M. tuberculosis. Patients were excluded from 
the study if: 1) they were not residents of Karachi; 
2) they exhibited resistance to at least isoniazid and 
rifampicin; and/or 3) they had severe illness.
The study had a quasi-experimental cohort design 
(in many respects it conforms to an experimental 
study, except for treatment randomisation). At the 
treatment centre offering both strategies, the benefi ts 
and limitations of each were explained to each par-
ticipant, who was then asked to choose either daily 
clinic DOT at the health centre, to be observed by 
staff, or family DOT, to be observed at home by a 
family member of the patient’s choice.
Treatment regimens and data collection
At the fi rst treatment visit after diagnosis, eligible pa-
tients were approached by a clinic nurse who ex-
plained the purpose, process and voluntary nature of 
the study and sought verbal consent from the patient 
(or guardian if the patient was aged <16 years). Clinic 
DOT patients were advised to attend the clinic dur-
ing working hours to take their medication under ob-
servation by a clinic nurse. Each patient was advised 
to attend 5 days/week for the fi rst 8 weeks (12 weeks 
for retreatment patients), followed by 3 days/week for 
the continuation phase. The treatment regimens used 
were as recommended by the WHO and Pakistan’s 
NTP guidelines, i.e., an 8-month regimen (2HREZ/
6HE for new and 2SHREZ/1HREZ/5HRE for re-
treatment patients*). Apart from the difference in 
DOT, patients in both cohorts received the same case 
management, and all patients received drugs free of 
charge. Efforts were made to ensure that care and 
health education for patients in clinic and family 
DOT groups were delivered at each visit by the same 
health centre staff members.
At enrolment, data were obtained on baseline 
s ocio-demographic and health centre related vari-
ables for each study patient using a structured ques-
tionnaire. At subsequent visits (start of treatment, at 
months 2, 3 and 5 and at the end of treatment), the 
questionnaire was completed with data on bacterio-
logical test results. Information was also collected on 
treatment duration and outcome, satisfaction with 
health services, satisfaction with health care provid-
er’s attitude and adherence to treatment. Incomplete 
entries or suspected reporting inaccuracies by patients 
* H = isonazid; R = rifampicin; E = ethambutol; Z = pyrazin-
amide; S = streptomycin. The numbers before the letters indicate 
the length of each phase of treatment, in months.
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and/or health centre staff were addressed in subse-
quent visits by the research team. An adherence card 
was signed and dated by a nurse at each visit and re-
tained in the patient’s clinic fi le. Family DOT patients/ 
guardians visited the clinic every week. Responsibil-
ity for adherence lay with the patient/guardian; pa-
tients completed their own adherence cards for each 
day of pill taking, and a nurse recorded the weekly col-
lection of drugs during the weekly visit. Based on the 
treating physician’s assessment, adherence to treat-
ment (defi ned as the number of weeks of treatment 
completed, and not the number of doses of medica-
tion) was also noted. The two WHO/Union-defi ned 
outcome variables, i.e., ‘cure’ and ‘treatment success’, 
were analysed.15 Other possible outcomes considered 
were also adapted from WHO/Union guidelines.15
Sample size 
The planned sample size was 300 patients in each 
cohort. This provided 90% power, at 5% signifi -
cance level, to detect a difference of at least 15% be-
tween the proportions of successful treatment and/or 
cured patients in the clinic and family DOT groups, 
assuming a rate of 50% of these events in the lat -
ter group and approximately 30% refusals and de-
faults in each cohort. 
Ethical considerations
At each treatment centre the benefi ts and limitations 
of clinic or family DOT supervision modalities were 
explained to each patient, and verbal consent was 
sought from all patients/guardians. The study was ap-
proved by the Ethics Review Committee of Aga Khan 
University, Karachi, Pakistan. 
Statistical analyses
Data were double entered and managed using Epi 
Info Version 6.04 (Centers for Disease Control and 
Prevention, Atlanta, GA, USA) and analysed using 
Stata 9.2 (StataCorp LP, College Station, TX, USA). 
Type of supervision (clinic vs. family DOT) was the 
main exposure variable. Two main outcome variables, 
cure and treatment success (cured plus treatment 
completed), were analysed. All the analyses were on 
an intention-to-treat basis. The χ2 test was used to 
compare the distribution of demographic, socio-
e conomic and health care facility variables at base-
line between the clinic and family DOT groups. We 
computed the difference with 95% confi dence inter-
vals (95%CI) between proportions of patients with 
an outcome of ‘cured’ or treatment success in both 
cohorts. A univariable log-binomial regression model 
was used to compute the unadjusted relative risk 
(RR) and 95%CIs to evaluate the relationship be-
tween supervision modality and ‘cured’ status. To ad-
just for confounding, factors related to ‘cured’ status 
(P ⩽ 0.15) on univariable analyses were considered 
for inclusion in multivariable log-binomial regression 
Table 1 Baseline characteristics of pulmonary tuberculosis 
patients in clinic DOT and family DOT supervision modalities in 
a cohort study, Karachi, Pakistan
Variable Total
Clinic
DOT
(n = 295)
Family 
DOT
(n = 287)
P valuen % n %
Age (completed years)
 ⩽20
 21–40
 41–60
 >60
190
254
112
 26
103
131
 51
 10
34.9
44.4
17.3
 3.4
 87
123
 61
 16
30.3
42.9
21.3
 5.6
  0.062
Sex
 Female
 Male
282
300
144
151
48.8
51.2
138
149
48.1
51.9
  0.860
Marital status
 Separated
 Married
 Single
 33
312
237
 11
159
125
 3.7
53.9
42.4
 22
153
112
 7.7
53.3
39.0
  0.112
Mother tongue
 Balochi
 Sindhi 
 Punjabi
 Pushto
 Urdu
 Others
 27
 52
 92
102
224
 85
  7
 21
 50
 56
124
 37
 2.4
 7.1
17.0
19.0
42.0
12.5
 20
 31
 42
 46
100
 48
 7.0
10.8
14.6
16.0
34.8
16.7
  0.017
Religion
 Non-Muslim
 Muslim
 25
557
  8
287
 2.7
97.3
 17
270
 5.9
94.1
  0.056
Education (years of 
  schooling)
 Nil
 1–8
 9–10
 >10
330
132
 79
 41
160
 82
 41
 12
54.2
27.8
13.9
 4.1
170
 50
 38
 29
59.2
17.4
13.2
10.1
  0.002
Household size*
 >7
 ⩽7
283
299
165
130
59.9
44.1
118
169
41.1
58.9
<0.001
Household income 
  (rupees/month)†
 ⩽6000
 >6000 
448
134
241
 54
81.7 
18.3
207
 80
72.1
27.9
  0.006
Financial constraints‡
 No
 Yes
373
209
165
130
55.9
44.1
208
 79
72.5
27.5
<0.001
Patient category 
 Retreatment
 New patient
 62
520 
 27
268
 9.2
90.8
 35
252
12.2
87.8
  0.234
Distance (km) from 
  health centre
 >7
 ⩽7
539
 43
268
 27
90.8
 9.2
271
 16
94.4
 5.6
  0.099
Satisﬁ ed with health 
  worker’s attitude§
 No 
 Yes
 70
512
 34
261
11.5
88.5
 36
251
12.5
87.5
  0.706
Satisﬁ ed with health 
  services¶
 No 
 Yes
 73
509
 36
259
12.2
87.8
 37
250
12.9
87.1
  0.802
* Number of family members living in the same housing unit and sharing a 
kitchen.
† Total household income from all sources (rupees/month).
‡ Living comfortably with total household income or hand-to-mouth.
§ Whether the health care provider was friendly in dealing with and answer-
ing questions. 
¶ Availability of free drugs and availability of a health care provider to deal 
with you during your visit. 
DOT = directly observed treatment.
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models.18 The supervision modality, age, ethnicity 
(mother tongue), education, household size, house-
hold income (rupees/month) and fi nancial constraints 
were always retained in the models, either because of 
the signifi cant baseline differences between the clinic 
and family DOT groups (P < 0.05), or because of 
their socio-biological plausibility. Other variables were 
added to the model using a forward stepwise proce-
dure and were only retained if the log-likelihood ra-
tio test statistic was signifi cant (P < 0.05). When the 
log-binomial model failed to converge, a Poisson re-
gression model with robust variance computation 
was used. Adjusted RRs and their 95%CIs were used 
to interpret the fi nal model.
RESULTS
From 22 January 2003 to 18 January 2005, 582 pa-
tients were recruited into the study. No eligible pa-
tient refused to participate. Respectively 295 and 
287 patients were enrolled in the clinic and family 
DOT groups. There were signifi cant differences (P < 
0.05) between the groups with regard to the distribu-
tions of some of the demographic- and health centre-
related variables, such as ethnicity (defi ned by mother 
tongue), education, household size, total household 
income (rupees/month), fi nancial constraints and dis-
tance (km) from the health centre (Table 1). 
The overall proportion of ‘cured’ patients was re-
spectively 66% and 34% in the clinic and family 
DOT cohorts (absolute risk difference [RD] = 0.32; 
95%CI 0.24–0.39). By contrast, the proportion who 
‘completed treatment’ was signifi cantly lower in the 
clinic (10%) than in the family DOT (40%) cohort 
(RD = −0.30; 95%CI −0.36–−0.23). However, 
there was no signifi cant difference between the two 
cohorts in treatment success (RD = 0.02; 95%CI 
−0.05–0.09). Also, there were no meaningful differ-
ences between the two cohorts in the proportions of 
patients who defaulted (14% vs. 15%), transferred 
out (8% vs. 7%), failed (1% vs. 2%) or died (1% vs. 
2%; Table 2). Adherence was respectively 85% and 
82% in the clinic and family DOT cohorts. 
On univariable log-binomial regression analyses, 
supervision modality, education, fi nancial constraints, 
satisfaction with health care worker’s attitude and 
satisfaction with health services were signifi cantly as-
sociated with ‘cured’ status (P < 0.05; Table 3). The 
multivariable log-binomial regression model showed 
that patients in the clinic DOT group were nearly 
twice as likely to be cured as those in the family DOT 
group (adjusted RR 1.85; 95%CI 1.43–2.39). Pa-
tients satisfi ed with their health care worker’s attitude 
were about six times more likely to be cured than 
those who reported being dissatisfi ed (adjusted RR 
5.73; 95%CI 2.54–12.96; Table 4). 
DISCUSSION
In this study, the proportions of patients who achieved 
‘cure’ were respectively 66% and 34% in the clinic 
and family DOT groups. Clinic DOT patients were 
nearly twice as likely to be cured, after adjusting for 
the effects of other variables in the model. Although 
still short of the WHO target cure rate of 85%, the 
proportion of ‘cured’ patients in this evaluation 
(66%) is comparable with those recorded in ran-
domised controlled trials of DOTS in Northern Paki-
stan (64%)10 and in Thailand (62%).19 While there is 
evidently room for improvement, the proportion of 
‘cured’ patients in the clinic DOT group in our study 
was higher than the results obtained from two evalu-
ations of DOT in South Africa (34% and 41%).20 
The proportion who ‘completed treatment’ was 
lower in the clinic than in the family DOT group 
(10% vs. 40%). There was also no signifi cant differ-
ence in treatment success (i.e., ‘cured’ plus ‘completed 
treatment’) in the groups. These fi ndings corroborate 
those of an earlier controlled trial in Northern Paki-
stan, where a higher cure rate but lower ‘treatment 
completion’ rate were recorded in a health centre-
based supervision group than in two other groups.10 
Table 2 Treatment outcomes of pulmonary tuberculosis patients by sex and supervision modality in a cohort study, 
Karachi, Pakistan
Treatment outcome
a b c d e f c – f
Clinic DOT
(n = 295)
Family DOT
(n = 287)
RD (95%CI)
Male
(n = 151)
Female
(n =144)
Total
(n = 295)
Male
(n = 149)
Female
(n = 138)
Total
(n = 287)
Successful 
 Cured 100 (66)  94 (65) 194 (66)  51 (34)  47 (34)  98 (34)  0.32 (0.24–0.39)
 Treatment completed  13 (9)  17 (12)  30 (10)  54 (36)  60 (44) 114 (40) –0.30 (–0.36––0.23)
 All successful 113 (75) 111 (77) 224 (76) 105 (70) 107 (78) 212 (74)  0.02 (–0.05–0.09)
Unsuccessful
 Defaulted  27 (18)  15 (10)  42 (14)  26 (17)  18 (13)  44 (15)
 Transferred out  15 (10)   9 (6)  24 (8)  11 (7)   8 (6)  19 (7)
 Failed   2 (1) —   2 (1)   3 (2)   2 (2)   5 (2)
 Died   1 (1)   2 (1)   3 (1)   3 (2)   4 (3)   7 (2)
DOT = directly observed treatment; RD = risk difference; CI = conﬁ dence interval.
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Furthermore, the proportions of defaulting patients 
in the clinic (14%) and family DOT (15%) cohorts 
were about the same in our study. These proportions 
were nearly half the magnitude reported in North-
ern Pakistan among health facility staff (27%) and 
in home (family member or self; 32%) treatment 
s upervision modalities.10 A reduction in the pro-
portions of defaulters may be a result of growing 
awareness about the benefi ts of treatment completion 
among patients and family members, as a result of 
education received at health facilities or through 
media campaigns. 
In this type of study setting, 100% adherence in a 
family DOTS cohort is unlikely; however, the major-
ity of defaulting patients are labelled ‘treatment com-
pleted’ with no knowledge of their fi nal bacteriological 
Table 3 Univariable analysis of factors associated with ‘cured’ status of pulmonary tuberculosis patients treated with clinic DOT or 
family DOT, Karachi, Pakistan
Factor Total
Cured 
(n = 292)
Not cured
(n = 290)
Crude RR 95%CI P valuen % n %
Treatment supervision 
 Family DOT
 Clinic DOT
287
295
 98 
194 
33.6
66.4
189 
101 
65.2
34.8
1.00
1.93
—
1.61–2.31
<0.001
Age, completed years
 ⩽20
 21–40
 41–60
 >60
190
254
112
 26
104
121
 58
  9
35.6
41.4
19.9
 3.1
 86
133
 54
 17
29.7
45.9
18.6
 5.9
1.58
1.38
1.50
1.00
0.92–2.72
0.80–2.37
0.86–2.61
—
0.137
Sex
 Female
 Male
282
300
141
151
48.3
51.7
141
149
48.6
51.4
1.00
1.01
—
0.86–1.18
0.936
Marital status
 Separated
 Married
 Single
 33
312
237
 12
153
127
 4.1
52.4
43.5
 21
159
110
 7.2
54.8
37.9
1.00
1.35
1.47
—
0.85–2.15
0.92–2.35
0.151
Mother tongue
 Balochi
 Sindhi 
 Punjabi
 Pushto
 Urdu
 Others
 27
 52
 92
102
224
 85
 13
 26
 48
 52
123
 30
 4.5
 9.0
16.4
17.8
42.1
10.3
 14
 26
 44
 50
101
 55
 4.8
 9.0
15.2
17.2
34.8
19.0
1.00
1.04
1.08
1.06
1.14
0.73
—
0.65–1.67
0.70–1.68
0.69–1.64
0.76–1.72
0.45–1.91
0.082
Religion
 Non-Muslim
 Muslim
 25
557
 13
279
 4.5
95.5
 12
278
 4.1
95.9
1.00
0.96
—
0.66–1.42
0.852
Education, years of schooling
 Nil
 1–8
 9–10
 >10
330
132
 79
 41
147
 83
 41
 21
50.3
28.4
14.0
 7.2
183
 49
 38
 20
63.1
16.9
13.1
 6.9
1.00
1.41
1.17
1.15
—
1.18–1.69
0.91–1.49
0.83–1.59
0.005
Household size
 >7
 ⩽7
283
299
153
139
52.4
47.6
130
160
44.8
55.2
1.00
0.86
—
0.73–1.01
0.068
Household income, rupees/month
 ⩽6000
 >6000 
448
134
220
 72
 
75.3
24.7 
228
 62
78.6
21.4
1.00
1.09
—
0.91–1.31
0.348
Financial constraints
 No
 Yes
373
209
158
134
54.1
45.9
215
 75
74.1
25.9
1.00
1.51
—
1.30–1.77
<0.001
Patient category 
 Retreatment
 New patient
 62
520 
 33
259
11.3
88.7
 29
261
 
10.0
90.0
1.00
0.94
—
0.73–1.20
0.332
Distance from health centre, km
 >7
 ⩽7
539
 43
267
 25
91.4
 8.6
272
 18
93.8
 6.2
1.00
1.17
—
0.90–1.53
0.278
Satisﬁ ed with health worker’s attitude
 No
 Yes
 70
512
  6
286
 2.1
97.9
 64
226
22.1
77.9
1.00
6.52
—
3.02–14.06
<0.001
Satisﬁ ed with health services
 No 
 Yes
 73
509
  8
284
 2.7
97.3
 65
225
22.4
77.6
1.00
5.09
—
2.64–9.84
<0.001
DOT = directly observed treatment; RR = relative risk; CI = conﬁ dence interval.
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status. In 2005, treatment outcomes were unknown 
for an estimated 1.5 million smear-positive non-
DOTS patients globally, yet those patients were clas-
sifi ed as ‘treatment success’ after being combined 
with ‘cured’ patients, and analysed as one group.21 
This assumption is considered inappropriate due to 
the public health signifi cance of the unknown bacte-
riological status of patients classifi ed as ‘treatment 
completed’.21,22 
In this study, multivariable analysis showed that 
patients satisfi ed with their health care worker’s atti-
tude were more likely to achieve cure. It is recognised 
that DOT is more than a mechanical procedure for 
administering medicine to patients with TB: it is a 
bond between patient and health care worker, con-
veying recognition of the value of treatment.23,24 Staff 
support and health education are therefore likely to 
improve adherence to the treatment protocol, includ-
ing clinic visits and laboratory evaluation.25 As the 
model of staff support and health education has been 
shown to work elsewhere,26 it should be replicable in 
Pakistan and similar settings.
Some limitations should be considered when inter-
preting our results: information on several variables 
was self-reported by patients/guardians and/or health 
centre staff, and as such reporting inaccuracies could 
not be ruled out. Furthermore, the two cohorts may 
not be truly comparable in terms of all known and 
unknown confounders, although the multivariable 
log-binomial regression model did adjust for some 
covariate effects. Finally, lacking randomisation, we 
could not evaluate whether clinic DOT performed 
better at public or private centres, as all patients un-
der clinic DOT received care at public centres. 
CONCLUSION
Although well short of the WHO target of 85%, pub-
lic sector clinic DOT achieved twice the proportion 
of cured patients over private sector family DOT. 
Based on our fi ndings, efforts to enhance patient sat-
isfaction with provider’s attitude may improve treat-
ment outcomes. As a large number of TB patients ap-
proach private health care providers for diagnosis and 
treatment, Pakistan needs to implement the WHO’s 
public-private mix (PPM) approach to engage pri-
vate providers in TB control.27 Elsewhere, PPM ap-
proaches have yielded evidence of improvement in 
case detection and treatment outcomes in public sec-
tor health facilities,28–30 and effective implementation 
is likely to enhance TB control in both Pakistan and 
other resource-constrained settings. 
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DOT  in  urban  Pakistan i
C O N T E X T E  :   Cette étude quasi-expérimentale a visé à 
évaluer les résultats du traitement de la tuberculose (TB) 
défi nis selon l’Organisation Mondiale de la Santé (OMS) 
dans les modalités de traitement directement observé 
(DOT) dans une polyclinique (DOT clinique) et DOT 
par un membre de la famille (DOT famille) au Pakistan 
urbain.
M É T H O D E S  :   Nous avons enrôlé 582 patients atteints de 
TB à frottis positif provenant de 11 centres de traitement, 
soit pour DOT clinique (n = 295) soit pour DOT fa-
mille (n = 287). Les patients et/ou les membres de leur 
famille ont été interviewés pour toutes les déter minations 
de départ. Les résultats du traitement défi nis selon 
l’OMS ont été évalués à la fi n du traitement. On a infor-
matisé les proportions de patients «  guéris  ». On a uti-
lisé un modèle log-binomial pour évaluer les associations 
de différents facteurs avec le statut de «  guérison  ».
R É S U LTAT S  :   Les proportions de patients «  guéris  » ont 
été respectivement de 66% et de 34% dans les groupes 
DOT-clinique et -famille (différence de risque = 0,32 ; 
IC95% 0,24–0,39). Par comparaison avec ceux du groupe 
DOT-famille, les patients du groupe DOT-clinique ont 
été plus susceptibles d’être guéris (risque relatif ajusté 
[RRaj] 1,85 ; IC95% 1,43–2,39), tout comme l’étaient 
les patients satisfaits de l’attitude de leurs travailleurs de 
soins de santé (RRaj 5,73 ; IC95% 2,54–12,96).
C O N C L U S I O N  :   Par comparaison avec la stratégie DOT-
famille, la DOT-clinique a quasi doublé le taux de guéri-
son des patients tuberculeux. Des efforts pour l’optimi-
sation des attitudes des pourvoyeurs de soins en vue 
d’améliorer la satisfaction du patient, ainsi qu’une mise 
en œuvre effective de l’approche mixte publique-privée 
préconisée par l’OMS, pourraient améliorer la maîtrise de 
la TB dans ce contexte et dans des contextes similaires. 
M A R C O  D E  R E F E R E N C I A :   El presente estudio cuasi-
e xperimental tuvo como objeto comparar, con los crite-
rios de la Organización Mundial de la Salud (OMS), los 
desenlaces terapéuticos entre la modalidad de trata-
miento breve directamente observado (DOT) en el dis-
pensario (DOT-dispensario) y DOT en la familia (DOT-
familia) en una zona urbana en Pakistán. 
M É T O D O S :   Se incluyeron en el estudio 582 pacientes 
con tuberculosis (TB) y baciloscopia positiva, tratados 
ya sea mediante DOT-dispensario (n = 295) o DOT-
f amilia (n = 287) en 11 centros de atención. Los datos 
iniciales se obtuvieron en entrevistas a los pacientes o a 
los miembros de sus familias. Al fi nal del tratamiento se 
evaluaron los desenlaces terapéuticos con los criterios 
de la OMS. Se calculó la proporción de pacientes ‘cura-
dos’ y con un modelo de regresión logarítmico binomial 
se evaluaron las asociaciones entre los diferentes fac-
tores con la variable de ‘curación’.
R E S U LTA D O S :   La proporción de pacientes ‘curados’ fue 
66% en el grupo que recibió tratamiento en DOT-
d ispensario y 34% en el grupo DOT-familia (diferencia de 
riesgos 0,32; intervalo de confi anza [IC] del 95% 0,24–
0,39). Comparados con el otro grupo, los pacientes que 
recibieron DOT-dispensario tuvieron mayor probabilidad 
de alcanzar la curación (riesgo relativo ajustado [RRa] 
1,85; IC95% 1,43–2,39) y también los pacientes que afi r-
maban estar satisfechos con la actitud de su proveedor 
de atención sanitaria (RRa 5,73; IC95% 2,54–12,96).
C O N C L U S I Ó N :   El DOT-dispensario casi duplicó la tasa 
de curación de los pacientes tuberculosos en compara-
ción con DOT-familia. Las iniciativas encaminadas a 
mejorar las actitudes de los profesionales de salud y la 
satisfacción de los pacientes con el tratamiento y a opti-
mizar la ejecución efi caz el enfoque de la OMS en la 
colaboración entre el sector público y el sector privado 
podrían mejorar el control de la TB en los entornos 
semejantes.
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